Clinical Trial Update: Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) [Phase 1]

View source ↗

Summary

Phase 1 trial update for Botox as a treatment for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS); study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain Syndrome
• Prostatitis

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Queen's University | Conditions: Prostatitis, Chronic Pain Syndrome | Phase 1 | Status: TERMINATED | Results posted: 2019-03-11